Skip to main content
Top
Published in: Heart Failure Reviews 4/2015

Open Access 01-07-2015

Acid–base and electrolyte abnormalities in heart failure: pathophysiology and implications

Authors: Caterina Urso, Salvatore Brucculeri, Gregorio Caimi

Published in: Heart Failure Reviews | Issue 4/2015

Login to get access

Abstract

Electrolyte and acid–base abnormalities are a frequent and potentially dangerous complication in subjects with congestive heart failure. This may be due either to the pathophysiological alterations present in the heart failure state leading to neurohumoral activation (stimulation of the renin–angiotensin–aldosterone system, sympathoadrenergic stimulation), or to the adverse events of therapy with diuretics, cardiac glycosides, and ACE inhibitors. Subjects with heart failure may show hyponatremia, magnesium, and potassium deficiencies; the latter two play a pivotal role in the development of cardiac arrhythmias. The early identification of these alterations and the knowledge of the pathophysiological mechanisms are very useful for the management of these patients.
Literature
1.
go back to reference Ghali JK, Cooper R, Ford E (1990) Trends in hospitalization for heart failure in the United States, 1973–1986: evidence for increasing population prevalence. Arch Intern Med 150:769–773PubMed Ghali JK, Cooper R, Ford E (1990) Trends in hospitalization for heart failure in the United States, 1973–1986: evidence for increasing population prevalence. Arch Intern Med 150:769–773PubMed
2.
go back to reference Oster JR, Preston RA, Materson BJ (1994) Fluid and electrolyte disorders in congestive heart failure. Semin Nephrol 14:485–505PubMed Oster JR, Preston RA, Materson BJ (1994) Fluid and electrolyte disorders in congestive heart failure. Semin Nephrol 14:485–505PubMed
3.
go back to reference Gheorghiade M, Hellkamp AS, Pina IL et al (2005) Hemodynamic characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. J Am Coll Cardiol 45:145A Gheorghiade M, Hellkamp AS, Pina IL et al (2005) Hemodynamic characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. J Am Coll Cardiol 45:145A
4.
go back to reference Elisaf MS, Siamopoulos KC (1997) Acid–base and electrolyte abnormalities in patients with congestive heart failure. Exp Clin Cardiol 2:140–144 Elisaf MS, Siamopoulos KC (1997) Acid–base and electrolyte abnormalities in patients with congestive heart failure. Exp Clin Cardiol 2:140–144
5.
go back to reference Dargie HJ (1990) Interrelation of electrolytes and renin–angiotensin system in congestive heart failure. Am J Cardiol 65:28E–32EPubMed Dargie HJ (1990) Interrelation of electrolytes and renin–angiotensin system in congestive heart failure. Am J Cardiol 65:28E–32EPubMed
6.
go back to reference Adrogué HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342:1581–1589PubMed Adrogué HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342:1581–1589PubMed
7.
go back to reference Sica DA (2005) Hyponatremia and heart failure—pathophysiology and implications. Congest Heart Fail 11:274–277PubMed Sica DA (2005) Hyponatremia and heart failure—pathophysiology and implications. Congest Heart Fail 11:274–277PubMed
8.
go back to reference Klein L, O’Connor M, Leimberger D, Gattis-Stough W, Piña IL, Felker GM (2005) Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Chronic Heart Failure (OPTIME-CHF) Study. Circulation 111:2454–2460PubMed Klein L, O’Connor M, Leimberger D, Gattis-Stough W, Piña IL, Felker GM (2005) Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Chronic Heart Failure (OPTIME-CHF) Study. Circulation 111:2454–2460PubMed
9.
go back to reference Schrier RW (1990) Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Inter Med 113:155–159 Schrier RW (1990) Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Inter Med 113:155–159
10.
go back to reference Rademaker MT, Richards AM (2005) Cardiac natriuretic peptides for cardiac health. Clin Sci 108:23–36PubMed Rademaker MT, Richards AM (2005) Cardiac natriuretic peptides for cardiac health. Clin Sci 108:23–36PubMed
11.
go back to reference Schier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577–578 Schier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577–578
12.
go back to reference Schrier RW (2006) Water and sodium retention in edematous disorder: role of vasopressin and aldosterone. Am J Med 119:47–53 Schrier RW (2006) Water and sodium retention in edematous disorder: role of vasopressin and aldosterone. Am J Med 119:47–53
13.
go back to reference Dzau VJ (1987) Renal and circulatory mechanisms in congestive heart failure. Kidney Int 31:1402–1415PubMed Dzau VJ (1987) Renal and circulatory mechanisms in congestive heart failure. Kidney Int 31:1402–1415PubMed
14.
go back to reference Packer M (1995) Evolution of the neurohormonal hypothesis to explain the progression of chronic heart failure. Eur Heart J 16:4–6PubMed Packer M (1995) Evolution of the neurohormonal hypothesis to explain the progression of chronic heart failure. Eur Heart J 16:4–6PubMed
15.
go back to reference Brown JJ, Davies DL, Johnson VW, Lever AF, Robertson JI (1970) Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J 80:329–342PubMed Brown JJ, Davies DL, Johnson VW, Lever AF, Robertson JI (1970) Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J 80:329–342PubMed
16.
go back to reference Packer M, Medina Y, Yushak M (1984) Relationship between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure. J Am Coll Cardiol 3:1035–1043PubMed Packer M, Medina Y, Yushak M (1984) Relationship between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure. J Am Coll Cardiol 3:1035–1043PubMed
17.
go back to reference Ronco C, Haapio M, House AA (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539PubMed Ronco C, Haapio M, House AA (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539PubMed
18.
go back to reference Schrier RW (1975) Nonosmolar factors affecting renal water excretion. N Engl J Med 292:81–88PubMed Schrier RW (1975) Nonosmolar factors affecting renal water excretion. N Engl J Med 292:81–88PubMed
19.
go back to reference Cogan MG (1990) Angiotensin II a potent controller of sodium transport in the early proximal tubule. Hypertension 15:451–458PubMed Cogan MG (1990) Angiotensin II a potent controller of sodium transport in the early proximal tubule. Hypertension 15:451–458PubMed
20.
go back to reference Schuster VL, Kokko JP, Jacobson HR (1984) Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Investig 73:507–515PubMedCentralPubMed Schuster VL, Kokko JP, Jacobson HR (1984) Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Investig 73:507–515PubMedCentralPubMed
21.
go back to reference Heymes C, Bentall JK, Ratajczak P (2003) Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41:2164–2171PubMed Heymes C, Bentall JK, Ratajczak P (2003) Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41:2164–2171PubMed
22.
go back to reference Weber K (2001) Mechanisms of disease: aldosterone in chronic heart failure. N Engl J Med 345:1689–1697PubMed Weber K (2001) Mechanisms of disease: aldosterone in chronic heart failure. N Engl J Med 345:1689–1697PubMed
23.
go back to reference Goldsmith SR, Francis GS, Cowley AW (1986) Arginine vasopressin and the renal response to water loading in congestive heart failure. Am J Cardiol 58:295–299PubMed Goldsmith SR, Francis GS, Cowley AW (1986) Arginine vasopressin and the renal response to water loading in congestive heart failure. Am J Cardiol 58:295–299PubMed
24.
go back to reference Funayama H, Nakamura T, Saito T, Yoshimura A, Saito M, Kawakami M, Ishikawa SE (2004) Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure. Kidney Int 66:1387–1392PubMed Funayama H, Nakamura T, Saito T, Yoshimura A, Saito M, Kawakami M, Ishikawa SE (2004) Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure. Kidney Int 66:1387–1392PubMed
25.
go back to reference Nickel CH, Bingisser R, Morgenthaler NG (2012) The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med 10:7PubMedCentralPubMed Nickel CH, Bingisser R, Morgenthaler NG (2012) The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med 10:7PubMedCentralPubMed
26.
go back to reference De Luca L, Klein L, Udelson JE, Orlandi C, Sardella G, Fedele F, Gheorghiade M (2005) Hyponatremia in patients with heart failure. Am J Cardiol 96:19–23 De Luca L, Klein L, Udelson JE, Orlandi C, Sardella G, Fedele F, Gheorghiade M (2005) Hyponatremia in patients with heart failure. Am J Cardiol 96:19–23
28.
go back to reference Chow KM, Szeto CC, Wong TY, Leung CB, Li PK (2003) Risk factors for thiazide-induced hyponatraemia. QJM 96:911–917PubMed Chow KM, Szeto CC, Wong TY, Leung CB, Li PK (2003) Risk factors for thiazide-induced hyponatraemia. QJM 96:911–917PubMed
29.
go back to reference Chapman MD, Hanrahan R, McEwen J, Marley JE (2002) Hyponatraemia and hypokalaemia due to indapamide. Med J Aust 176:219–221PubMed Chapman MD, Hanrahan R, McEwen J, Marley JE (2002) Hyponatraemia and hypokalaemia due to indapamide. Med J Aust 176:219–221PubMed
30.
go back to reference Van Assen S, Mudde AH (1999) Severe hyponatraemia in an amiloride/hydrochlorothiazide-treated patient. Neth J Med 54:108–113PubMed Van Assen S, Mudde AH (1999) Severe hyponatraemia in an amiloride/hydrochlorothiazide-treated patient. Neth J Med 54:108–113PubMed
31.
go back to reference Costache II, Alexandrescu DM, Cimpoeşu D, Petriş OR, Petriş AO (2014) Hyponatremia-risk factor in patients with chronic heart failure—clinical, evolutive and therapeutic implications. Rev Med Chir Soc Med Nat Iasi 118:315–319PubMed Costache II, Alexandrescu DM, Cimpoeşu D, Petriş OR, Petriş AO (2014) Hyponatremia-risk factor in patients with chronic heart failure—clinical, evolutive and therapeutic implications. Rev Med Chir Soc Med Nat Iasi 118:315–319PubMed
32.
go back to reference Chin MH, Goldman L (1996) Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med 156:1814–1820PubMed Chin MH, Goldman L (1996) Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med 156:1814–1820PubMed
33.
go back to reference Chen MC, Chang HW, Cheng CI, Chen YH, Chai HT (2003) Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy. Cardiology 100:136–142. doi:10.1159/000073931 PubMed Chen MC, Chang HW, Cheng CI, Chen YH, Chai HT (2003) Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy. Cardiology 100:136–142. doi:10.​1159/​000073931 PubMed
34.
go back to reference Krumholz HM, Chen YT, Bradford WD, Cerese J (1999) Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care 5:715–723PubMed Krumholz HM, Chen YT, Bradford WD, Cerese J (1999) Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care 5:715–723PubMed
35.
go back to reference Zoghi M, Duygu H, Güngör H, Nalbantgil S, Yilmaz GM, Tülüce K (2008) The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center. Anadolu Kardiyol Derg 8:255–259PubMed Zoghi M, Duygu H, Güngör H, Nalbantgil S, Yilmaz GM, Tülüce K (2008) The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center. Anadolu Kardiyol Derg 8:255–259PubMed
36.
go back to reference Wong PS, Davidsson GK, Timeyin Warren A, Watson DJ, Vincent R (2002) Heart failure in patients admitted to hospital: mortality is still high. Eur J Intern Med 13:304–310PubMed Wong PS, Davidsson GK, Timeyin Warren A, Watson DJ, Vincent R (2002) Heart failure in patients admitted to hospital: mortality is still high. Eur J Intern Med 13:304–310PubMed
38.
go back to reference Chatterjee K (2009) Hyponatremia in heart failure. J Intensive Care Med 24:347–351PubMed Chatterjee K (2009) Hyponatremia in heart failure. J Intensive Care Med 24:347–351PubMed
39.
go back to reference Cleland JG, Dargie HJ, Robertson I, Robertson JI, East BW (1987) Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension. Br Heart J 58:230–238PubMedCentralPubMed Cleland JG, Dargie HJ, Robertson I, Robertson JI, East BW (1987) Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension. Br Heart J 58:230–238PubMedCentralPubMed
40.
go back to reference Macdonald JE, Struthers AD (2004) What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43:155–161PubMed Macdonald JE, Struthers AD (2004) What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43:155–161PubMed
41.
go back to reference Packer M (1990) Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure. Am J Cardiol 6:45–51 Packer M (1990) Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure. Am J Cardiol 6:45–51
42.
go back to reference Williams GH (2005) Aldosterone and heart failure: the rest of the story. Heart Fail Rev 10:5–6PubMed Williams GH (2005) Aldosterone and heart failure: the rest of the story. Heart Fail Rev 10:5–6PubMed
43.
go back to reference Cleland JG, Dargie HJ, Ford I (1987) Mortality in heart failure: clinical variables of prognostic value. Br Heart J 58:572–582PubMedCentralPubMed Cleland JG, Dargie HJ, Ford I (1987) Mortality in heart failure: clinical variables of prognostic value. Br Heart J 58:572–582PubMedCentralPubMed
44.
go back to reference Brown MJ, Brown DC, Murphy MB (1983) Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 309:1414–1419PubMed Brown MJ, Brown DC, Murphy MB (1983) Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 309:1414–1419PubMed
45.
go back to reference Podrid PJ (1990) Potassium and ventricular arrhythmias. Am J Cardiol 65:33–44 Podrid PJ (1990) Potassium and ventricular arrhythmias. Am J Cardiol 65:33–44
46.
go back to reference Salerno DM, Asinger RW, Elsperger J, Ruiz E, Hodges M (1987) Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction. Am J Cardiol 59:84–88PubMed Salerno DM, Asinger RW, Elsperger J, Ruiz E, Hodges M (1987) Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction. Am J Cardiol 59:84–88PubMed
47.
go back to reference Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowlwy A, Prescott RJ, Neilson JM, Fox KA (1998) Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98:1510–1516PubMed Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowlwy A, Prescott RJ, Neilson JM, Fox KA (1998) Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98:1510–1516PubMed
48.
go back to reference Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100:1311–1315PubMed Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100:1311–1315PubMed
49.
go back to reference Pitt B, Remme W, Zannad F (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321PubMed Pitt B, Remme W, Zannad F (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321PubMed
50.
go back to reference Leier CV, Dei Cas L, Metra M (1994) Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J 128:564–574PubMed Leier CV, Dei Cas L, Metra M (1994) Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J 128:564–574PubMed
51.
go back to reference Cohn J, Kowey P, Whelton P, Prisant M (2000) New guidelines for potassium replacement in clinical practice. Arch Intern Med 160:2429–2436PubMed Cohn J, Kowey P, Whelton P, Prisant M (2000) New guidelines for potassium replacement in clinical practice. Arch Intern Med 160:2429–2436PubMed
52.
go back to reference Srivastava TN, Young DB (1995) Impairment of cardiac function by moderate potassium depletion. J Card Fail 1:195–200PubMed Srivastava TN, Young DB (1995) Impairment of cardiac function by moderate potassium depletion. J Card Fail 1:195–200PubMed
53.
go back to reference Sudhir K, Kurtz TW, Yock PG, Connolly AJ, Morris RC (1993) Potassium preserves endothelial function and enhances aortic compliance in Dahl rats. Hypertension 22:3 Sudhir K, Kurtz TW, Yock PG, Connolly AJ, Morris RC (1993) Potassium preserves endothelial function and enhances aortic compliance in Dahl rats. Hypertension 22:3
54.
go back to reference Taddei S, Mattei P, Virdis A, Sudano I, Ghiadoni L, Salvetti A (1994) Effect of potassium on vasodilation to acetylcholine in essential hypertension. Hypertension 23:485–490PubMed Taddei S, Mattei P, Virdis A, Sudano I, Ghiadoni L, Salvetti A (1994) Effect of potassium on vasodilation to acetylcholine in essential hypertension. Hypertension 23:485–490PubMed
55.
go back to reference Campbell WB, Schmitz JM (1978) Effect of alterations in dietary potassium on the pressor and steroidogenic effects of angiotensins II and III. Endocrinology 103:2098–2104PubMed Campbell WB, Schmitz JM (1978) Effect of alterations in dietary potassium on the pressor and steroidogenic effects of angiotensins II and III. Endocrinology 103:2098–2104PubMed
56.
go back to reference Young DB, Lin H, McCabe RD (1995) Potassium’s cardiovascular protective mechanisms. Am J Physiol 268:R825–R837PubMed Young DB, Lin H, McCabe RD (1995) Potassium’s cardiovascular protective mechanisms. Am J Physiol 268:R825–R837PubMed
57.
go back to reference Barri YM, Wingo CS (1997) The effects of potassium depletion and supplementation on blood pressure: a clinical review. Am J Med Sci 314:37–40PubMed Barri YM, Wingo CS (1997) The effects of potassium depletion and supplementation on blood pressure: a clinical review. Am J Med Sci 314:37–40PubMed
58.
go back to reference Bielecka-Dabrowa A, Mikhailidis D, Jones L (2012) The meaning of hypokalemia in heart failure. Int J Cardiol 158:12–17PubMed Bielecka-Dabrowa A, Mikhailidis D, Jones L (2012) The meaning of hypokalemia in heart failure. Int J Cardiol 158:12–17PubMed
59.
go back to reference Ward J, Cameron I (1984) Adaptation of the cardiac muscle sodium pump to chronic potassium deficiency. Cardiovasc Res 18:257–263PubMed Ward J, Cameron I (1984) Adaptation of the cardiac muscle sodium pump to chronic potassium deficiency. Cardiovasc Res 18:257–263PubMed
60.
go back to reference Erdmann E, Bolte HD, Luderitz B (1971) The (Na+–K+) ATPase activity of guinea-pig heart muscle in potassium deficiency. Arch Biochem Biophys 145:121–125PubMed Erdmann E, Bolte HD, Luderitz B (1971) The (Na+–K+) ATPase activity of guinea-pig heart muscle in potassium deficiency. Arch Biochem Biophys 145:121–125PubMed
61.
go back to reference Shattock M, Matsuura H, Ward J (1994) Sodium pump current measured in cardiac ventricular myocytes isolated from control and potassium depleted rabbits. Cardiovasc Res 28:1854–1862PubMed Shattock M, Matsuura H, Ward J (1994) Sodium pump current measured in cardiac ventricular myocytes isolated from control and potassium depleted rabbits. Cardiovasc Res 28:1854–1862PubMed
62.
go back to reference Blomstrom-Lundqvist C, Caidahl K, Olsson B, Rudins A (1989) Electrocardiographic findings and frequency of arrhythmias in Bartter’s syndrome. Br Heart J 61:274–279PubMedCentralPubMed Blomstrom-Lundqvist C, Caidahl K, Olsson B, Rudins A (1989) Electrocardiographic findings and frequency of arrhythmias in Bartter’s syndrome. Br Heart J 61:274–279PubMedCentralPubMed
63.
go back to reference Li M, Xiao J, Yan S (1996) Changes in intracellular K+ concentration and ATPase activity of myocardiocytes in early stage of burn injury. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 12:177–179PubMed Li M, Xiao J, Yan S (1996) Changes in intracellular K+ concentration and ATPase activity of myocardiocytes in early stage of burn injury. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 12:177–179PubMed
64.
go back to reference Rude RK (1989) Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency. Am J Cardiol 63:31–34 Rude RK (1989) Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency. Am J Cardiol 63:31–34
65.
go back to reference Gattlieb SS (1989) Importance of magnesium in congestive heart failure. Am J Cardiol 63:39–42 Gattlieb SS (1989) Importance of magnesium in congestive heart failure. Am J Cardiol 63:39–42
66.
go back to reference Douban S, Brodsky MA, Whang DD, Whang R (1996) Significance of magnesium congestive heart failure. Am Heart J 132:664–671PubMed Douban S, Brodsky MA, Whang DD, Whang R (1996) Significance of magnesium congestive heart failure. Am Heart J 132:664–671PubMed
67.
go back to reference Milionisa HJ, Alexandridesa GE, Liberopoulosa EN, Bairaktarib ET, Goudevenosc J, Elisaf MS (2002) Hypomagnesemia and concurrent acid–base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail 4:167–173 Milionisa HJ, Alexandridesa GE, Liberopoulosa EN, Bairaktarib ET, Goudevenosc J, Elisaf MS (2002) Hypomagnesemia and concurrent acid–base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail 4:167–173
68.
go back to reference Schwinger RH, Erdman E (1992) Heart failure and electrolyte disturbances. Methods Find Exp Clin Pharmacol 14:315–325PubMed Schwinger RH, Erdman E (1992) Heart failure and electrolyte disturbances. Methods Find Exp Clin Pharmacol 14:315–325PubMed
69.
go back to reference Wester PO (1992) Electrolyte balance in heart failure and the role of magnesium ions. Am J Cardiol 70:44–49 Wester PO (1992) Electrolyte balance in heart failure and the role of magnesium ions. Am J Cardiol 70:44–49
70.
go back to reference Wu X, Ackermann U, Sonnenberg H (1995) Potassium depletion and salt-sensitive hypertension in DAHL rats: effect on calcium, magnesium, and phosphate excretions. Clin Exp Hypertens 17:989–1008PubMed Wu X, Ackermann U, Sonnenberg H (1995) Potassium depletion and salt-sensitive hypertension in DAHL rats: effect on calcium, magnesium, and phosphate excretions. Clin Exp Hypertens 17:989–1008PubMed
71.
go back to reference Solomon R (1987) The relationship between disorders of Kq and Mgq homeostasis. Semin Nephrol 2:253–262 Solomon R (1987) The relationship between disorders of Kq and Mgq homeostasis. Semin Nephrol 2:253–262
72.
go back to reference Shils ME (1980) Magnesium, calcium and parathyroid interactions. Ann NY Acad Sci 355:165–178PubMed Shils ME (1980) Magnesium, calcium and parathyroid interactions. Ann NY Acad Sci 355:165–178PubMed
73.
go back to reference Ralston MA, Mumane MR, Unverferth DV, Leier CV (1990) Serum and tissue magnesium concentrations in patients with heart failure and serious ventricular arrhythmias. Ann Intern Med 113:841–846PubMed Ralston MA, Mumane MR, Unverferth DV, Leier CV (1990) Serum and tissue magnesium concentrations in patients with heart failure and serious ventricular arrhythmias. Ann Intern Med 113:841–846PubMed
74.
go back to reference Seelig MS, Haddy FJ (1980) Magnesium and the arteries. Effects of magnesium deficiency on arteries and on the retention of sodium, potassium and calcium. In: Cantin M, Seelig MS (eds) Magnesium in health and disease. SP Medical and Scientific Books, New York, pp 605–638 Seelig MS, Haddy FJ (1980) Magnesium and the arteries. Effects of magnesium deficiency on arteries and on the retention of sodium, potassium and calcium. In: Cantin M, Seelig MS (eds) Magnesium in health and disease. SP Medical and Scientific Books, New York, pp 605–638
75.
go back to reference Stevenson MM, Yoder I (1972) Studies of platelet aggregation, plasma adenosine diphosphate breakdown, and blood coagulation in magnesium deficient calves and rats. Thromh Diarh Herrrorrh 22:299–305 Stevenson MM, Yoder I (1972) Studies of platelet aggregation, plasma adenosine diphosphate breakdown, and blood coagulation in magnesium deficient calves and rats. Thromh Diarh Herrrorrh 22:299–305
76.
go back to reference Altura BM, Altura BT (1986) Biochemistry and pathophysiology of congestive heart failure: is there a role for magnesium! Magnesium 5:134–143PubMed Altura BM, Altura BT (1986) Biochemistry and pathophysiology of congestive heart failure: is there a role for magnesium! Magnesium 5:134–143PubMed
77.
go back to reference Gottlieb SS, Baruch L, Kukin ML, Bemstein JL, Fisher ML, Packer M (1990) Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Cardiol 6:827–883 Gottlieb SS, Baruch L, Kukin ML, Bemstein JL, Fisher ML, Packer M (1990) Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Cardiol 6:827–883
78.
go back to reference Levine SN, Rheams CN (1985) Hypocalcemic heart failure. Am J Med 78:1033–1035PubMed Levine SN, Rheams CN (1985) Hypocalcemic heart failure. Am J Med 78:1033–1035PubMed
79.
go back to reference Krapf R, Jaeger P, Hulter HN (1992) Chronic respiratory alkalosis induces renal PTH resistance, hyperphosphatemia and hypocalcemia in humans. Kidney Int 42:727–734PubMed Krapf R, Jaeger P, Hulter HN (1992) Chronic respiratory alkalosis induces renal PTH resistance, hyperphosphatemia and hypocalcemia in humans. Kidney Int 42:727–734PubMed
80.
go back to reference Bourdeau JE, Buss SL, Vurek GG (1982) Inibition of calcium absorption in the cortical thick ascending limb of Henle’s loop by furosemide. J Pharmacol Exp Ther 221:815–819PubMed Bourdeau JE, Buss SL, Vurek GG (1982) Inibition of calcium absorption in the cortical thick ascending limb of Henle’s loop by furosemide. J Pharmacol Exp Ther 221:815–819PubMed
81.
go back to reference Rimailho A, Bouchard P, Aschaison G (1985) Improvement of hypocalcemic cardiomyopathy by correction of serum calcium level. Am Heart J 109:611–613PubMed Rimailho A, Bouchard P, Aschaison G (1985) Improvement of hypocalcemic cardiomyopathy by correction of serum calcium level. Am Heart J 109:611–613PubMed
82.
go back to reference Gaasbeek A, Meinders AE (2005) Hypophosphatemia. An update on its etiology and treatment. Am J Med 118:1094–1101PubMed Gaasbeek A, Meinders AE (2005) Hypophosphatemia. An update on its etiology and treatment. Am J Med 118:1094–1101PubMed
83.
go back to reference Darsee JR, Nutter DO (1978) Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia. Ann Inter Med 89:867–870 Darsee JR, Nutter DO (1978) Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia. Ann Inter Med 89:867–870
84.
go back to reference Plischke M, Albrecht C, Bielesz B, Shayganfar S (2011) Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure. Eur J Clin Investig 42:649–656 Plischke M, Albrecht C, Bielesz B, Shayganfar S (2011) Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure. Eur J Clin Investig 42:649–656
85.
go back to reference Wu F, Zhang EY, Zhang J, Bache RJ, Beard DA (2008) Phosphate metabolite concentrations and ATP hydrolysis potential normal and ischaemic hearts. J Physiol 586:4193–4208PubMedCentralPubMed Wu F, Zhang EY, Zhang J, Bache RJ, Beard DA (2008) Phosphate metabolite concentrations and ATP hydrolysis potential normal and ischaemic hearts. J Physiol 586:4193–4208PubMedCentralPubMed
86.
go back to reference He MX, Wang S, Downey HF (1997) Correlation between myocardial contractile force and cytosolic inorganic phosphate during early ischemia. Am J Physiol 272:1333–1341 He MX, Wang S, Downey HF (1997) Correlation between myocardial contractile force and cytosolic inorganic phosphate during early ischemia. Am J Physiol 272:1333–1341
87.
go back to reference Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627–2633PubMed Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627–2633PubMed
88.
go back to reference Milionis HJ, Alexandrides GE, Liberopoulos EL, Bairaktari ET, Goudevenos J, Elisaf MS (2002) Hypomagnesemia and concurrent acid–base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail 4:167–173PubMed Milionis HJ, Alexandrides GE, Liberopoulos EL, Bairaktari ET, Goudevenos J, Elisaf MS (2002) Hypomagnesemia and concurrent acid–base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail 4:167–173PubMed
89.
go back to reference Kuwahara T, Kawai C (1992) Acid–base disturbances in heart failure. Nippon Rinsho 50:2173–2177PubMed Kuwahara T, Kawai C (1992) Acid–base disturbances in heart failure. Nippon Rinsho 50:2173–2177PubMed
90.
go back to reference Frangiosa A, De Santo LS, De Santo NG, Anastasio P, Favazzi P, Cirillo E, Cotrufo M, Adroguè HJ (2002) Acid–base state in patients after cardiac transplantation. Am J Nephrol 22:332–337PubMed Frangiosa A, De Santo LS, De Santo NG, Anastasio P, Favazzi P, Cirillo E, Cotrufo M, Adroguè HJ (2002) Acid–base state in patients after cardiac transplantation. Am J Nephrol 22:332–337PubMed
91.
go back to reference Kratky V, Bartonova J, Hrdina R (1990) Nektere metabolicke a acidobazicke zmeny pri intenzvini diureticke lecbe srdecni slabosti. Vnitr Lek 36:330–341PubMed Kratky V, Bartonova J, Hrdina R (1990) Nektere metabolicke a acidobazicke zmeny pri intenzvini diureticke lecbe srdecni slabosti. Vnitr Lek 36:330–341PubMed
92.
go back to reference Sterns RH (2003) Fluid, electrolyte, and acid–base disturbances. NephSAP 2:3–8 Sterns RH (2003) Fluid, electrolyte, and acid–base disturbances. NephSAP 2:3–8
93.
go back to reference Selden DW, Rector FC (1972) The generation and maintenance of metabolic alkalosis. Kidney Int 1:306–321 Selden DW, Rector FC (1972) The generation and maintenance of metabolic alkalosis. Kidney Int 1:306–321
94.
go back to reference Pitts RF, Lotspeich WD (1996) Bicarbonate and the renal regulation of acid–base balance. Am J Physiol 147:138–154 Pitts RF, Lotspeich WD (1996) Bicarbonate and the renal regulation of acid–base balance. Am J Physiol 147:138–154
95.
go back to reference Kassirer JP, London AM, Goldman DM (1970) On the pathogenesis of metabolic alkalosis in hyperaldosteronism. Am J Med 49:306–315PubMed Kassirer JP, London AM, Goldman DM (1970) On the pathogenesis of metabolic alkalosis in hyperaldosteronism. Am J Med 49:306–315PubMed
96.
97.
go back to reference Shirakabe A, Hata N, Kobayashi N (2012) Clinical significance of acid–base balance in an emergency setting in patients with acute heart failure. J Cardiol 60:288–294PubMed Shirakabe A, Hata N, Kobayashi N (2012) Clinical significance of acid–base balance in an emergency setting in patients with acute heart failure. J Cardiol 60:288–294PubMed
98.
go back to reference Peixoto Aldo J, Alpern Robert J (2013) Acid–base and electrolyte teaching case treatment of severe metabolic alkalosis in a patient with congestive heart failure. Am J Kidney 61:822–827 Peixoto Aldo J, Alpern Robert J (2013) Acid–base and electrolyte teaching case treatment of severe metabolic alkalosis in a patient with congestive heart failure. Am J Kidney 61:822–827
99.
go back to reference Light RW, George RB (1983) Serial pulmonary function in patients with acute heart failure. Arch Intern Med 143:429–433PubMed Light RW, George RB (1983) Serial pulmonary function in patients with acute heart failure. Arch Intern Med 143:429–433PubMed
100.
go back to reference Niset G, Ninane V, Antoine M, Yernault JC (1993) Respiratory dysfunction in congestive heart failure: correction after heart transplantation. Eur Respir J 6:1197–1201PubMed Niset G, Ninane V, Antoine M, Yernault JC (1993) Respiratory dysfunction in congestive heart failure: correction after heart transplantation. Eur Respir J 6:1197–1201PubMed
101.
go back to reference Paintal AS (1970) The mechanism of excitation of type J receptors and the J reflex. Ciba Foundation Symposium-Breathing: Hering-Breuer Centenary Symposium Paintal AS (1970) The mechanism of excitation of type J receptors and the J reflex. Ciba Foundation Symposium-Breathing: Hering-Breuer Centenary Symposium
102.
go back to reference Moster WG, Reirer C, Gardier RW (1969) Cardiac output and postganglionic sympathetic activity during acute respiratory alkalosis. Anesthesiology 31:28–34PubMed Moster WG, Reirer C, Gardier RW (1969) Cardiac output and postganglionic sympathetic activity during acute respiratory alkalosis. Anesthesiology 31:28–34PubMed
103.
go back to reference JCS Joint Working Group (2013) Guidelines for treatment of acute heart failure (JCS 2011). Circ J 77:2157–2201 JCS Joint Working Group (2013) Guidelines for treatment of acute heart failure (JCS 2011). Circ J 77:2157–2201
104.
go back to reference McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847PubMed McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847PubMed
105.
Metadata
Title
Acid–base and electrolyte abnormalities in heart failure: pathophysiology and implications
Authors
Caterina Urso
Salvatore Brucculeri
Gregorio Caimi
Publication date
01-07-2015
Publisher
Springer US
Published in
Heart Failure Reviews / Issue 4/2015
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-015-9482-y

Other articles of this Issue 4/2015

Heart Failure Reviews 4/2015 Go to the issue